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Abstract Purpose: Sepsis com-
monly contributes to acute kidney
injury (AKI); however, the frequency
with which sepsis develops as a
complication of AKI and the clinical
consequences of this sepsis are
unknown. This study examined the
incidence of, and outcomes associ-
ated with, sepsis developing after
AKI. Methods: We analyzed data
from 618 critically ill patients enrol-
led in a multicenter observational
study of AKI (PICARD). Patients
were stratified according to their
sepsis status and timing of incident
sepsis relative to AKI diagnosis.
Results: We determined the associ-
ations among sepsis, clinical
characteristics, provision of dialysis,
in-hospital mortality, and length of
stay (LOS), comparing outcomes
among patients according to their
sepsis status. Among the 611 patients
with data on sepsis status, 174 (28%)
had sepsis before AKI, 194 (32%)
remained sepsis-free, and 243 (40%)
developed sepsis a median of 5 days
after AKI. Mortality rates for patients
with sepsis developing after AKI
were higher than in sepsis-free
patients (44 vs. 21%; p \ 0.0001) and
similar to patients with sepsis pre-
ceding AKI (48 vs. 44%; p = 0.41).
Compared with sepsis-free patients,
those with sepsis developing after
AKI were also more likely to be
dialyzed (70 vs. 50%; p \ 0.001) and
had longer LOS (37 vs. 27 days;
p \ 0.001). Oliguria, higher fluid
accumulation and severity of illness
scores, non-surgical procedures after
AKI, and provision of dialysis were
predictors of sepsis after AKI.
Conclusions: Sepsis frequently
develops after AKI and portends a
poor prognosis, with high mortality
rates and relatively long LOS. Future
studies should evaluate techniques to
monitor for and manage this compli-
cation to improve overall prognosis.
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Introduction
In critically ill patients, acute kidney injury (AKI) is
associated with a high mortality [1–5]; however, the
mechanism(s) responsible for the increased mortality and
morbidity risks associated with AKI remain elusive. AKI
frequently complicates sepsis or septic shock [1, 6, 7].
So-called septic AKI has been independently associated
with an increased risk for death and longer hospital stay
[6]. Prior studies have focused on the incidence, risk
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factors, and prognosis of sepsis-induced AKI [6, 8–12].
Few studies have examined the incidence of, and conse-
quences associated with, sepsis developing after AKI
[13].
The Program to Improve Care in Acute Renal Disease
(PICARD) was an observational study of 618 intensive
care unit (ICU) patients with AKI from five academic
medical centers in North America. PICARD was designed
to identify demographic, clinical, and process of care
factors associated with favorable and adverse outcomes
after AKI [14]. We hypothesized that sepsis develops
frequently after AKI, and is associated with mortality, non-
recovery of kidney function, and longer lengths of stay.
Materials and methods
Study participants
Over a 31-month period (February 1999 to August 2001),
PICARD study personnel evaluated all critically ill
patients consulted for AKI at five academic medical cen-
ters for potential study participation. Given the large
number of ICU beds at Cleveland Clinic Foundation, we
randomized one in six patients for possible study inclu-
sion, to avoid single-center over-representation. A detailed
description of PICARD inclusion and exclusion criteria,
data elements, data collection, and management strategies
has been described elsewhere [14]. In PICARD, AKI was
defined as an increase in serum creatinine C44 lmol/L
when baseline serum creatinine was \133 lmol/L, or an
increase in serum creatinine C88 lmol/L when baseline
serum creatinine was C133 lmol/L and\442 lmol/L (to
convert lmol/L into mg/dL, divide by 88.4). Baseline
serum creatinine was defined as the closest value within
6 months of hospital admission. Exclusion criteria inclu-
ded age\18 years, prisoners, pregnancy, serum creatinine
[442 lmol/L, previous dialysis, kidney transplantation,
AKI from urinary tract obstruction, and hypovolemia
responsive to fluid. All interventions were determined by
the attending physicians and not influenced by the study
personnel. The institutional review boards at each site
approved the study protocol. Informed consent was
required from all study participants or their proxy. In this
study, we included all patients (611/618; 99%) who had
data available on sepsis status.
Determination of sepsis status
Patients were evaluated for the presence of systemic
inflammatory response syndrome (SIRS) and sepsis as
defined by American College of Chest Physicians/Society
of Critical Care Medicine guidelines [15]. Specifically,
SIRS was defined as a systemic inflammatory response to
an unspecified stimulus manifested by the presence of two
or more of the following: (a) body temperature greater than
38C or less than 36C; (b) heart rate greater than 90 beats/
min; (c) on a ventilator, or tachypnea, manifested by a
respiratory rate greater than 20 breaths/min, or hyperven-
tilation, as indicated by a PaCO2 of less than 32 mmHg;
and (d) a white blood cell count greater than 12,000/mm3 or
less than 4,000/mm3, or the presence of more than 10%
immature neutrophils. Sepsis was diagnosed when patients
met criteria for SIRS and an infectious source was docu-
mented or strongly suspected on the basis of clinical
suspicion and tests ordered by treating physicians [15]. The
sepsis status was computed daily from these variables.
Patients were then classified into one of three groups:
patients who remained sepsis-free, those who developed
sepsis prior to AKI diagnosis, and those who developed
sepsis post-AKI diagnosis. Data on focus of infection
during ICU stay were derived from ICD-9 codes (Table 1).
Definitions
We computed fluid balance for each day using the sum of
daily fluid intake (in liters) from which we subtracted
total output (in liters). To quantify cumulative fluid bal-
ance in relation to body weight, we used the following
formula: (
P
daily (fluid intake (L) - total output (L))/
body weight (in kg))/100 [16]. ‘‘Fluid overload’’ was
defined as[10% fluid accumulation over baseline weight
at hospital admission [17]. Invasive non-surgical proce-
dures were tracked through the observation period. These
included pulmonary artery catheter placement, cardiac
procedures (other intracardiac catheters, angioplasties,
atherectomies, pacemaker placements), extracorporeal
membrane oxygenation (ECMO), chest tube placement,
bronchoscopy, thoracentesis, paracentesis, burn-related
procedures, radiologic procedures (stents, other angio-
plasties), internal organ biopsy, plasmapheresis, and
transjugular intrahepatic portosystemic shunt (TIPS).
Recovery of kidney function was defined as a final serum
creatinine concentration either within 20% or 44 lmol/L
of the baseline serum creatinine value. For patients
requiring dialysis, the definition of recovery also included
independence from dialysis for at least 3 days prior to
death or hospital discharge. Sequential Organ Failure
Assessment (SOFA) scores [18] were computed daily.
Statistical analyses
Continuous variables were expressed as mean ± standard
deviation (SD) or median and interquartile range and
compared by using general linear models with Tukey’s
adjustment for multiple pairwise comparisons or the
Wilcoxon rank-sum test, where appropriate. Categorical
variables were expressed as proportions and compared
with the chi-square or Fisher exact test, where
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Mean age (years) 55.2 ± 16.2 62.9 ± 15.3 59.8 ± 16.3 \0.0001a
0.004c
% Male 60% 59% 59% NS
% White 78% 82% 79% NS
% Chronic kidney disease 25% 42% 23% 0.0003a \0.0001b
% With surgery prior to AKI diagnosis 44% 54% 52% 0.03a
RIFLE category 0.35
Not classified (n = 120)d 29 (24%) 45 (38%) 46 (38%)
Risk (n = 99) 30 (30%) 36 (36%) 33 (33%)
Injury (n = 49) 15 (31%) 12 (24%) 22 (45%)
Failure (n = 302) 95 (31%) 86 (28%) 121 (40%)
Etiology of AKI (not mutually exclusive)
Acute tubular necrosis/ischemia 80% 63% 69% 0.0005
Cardiac 13% 23% 21% 0.02
Liver factors 7% 10% 14% NS
Nephrotoxic 26% 26% 27% NS
Obstruction 2% 1% 1% NS
Pre-renal 15% 17% 17% NS
Multifactorial 8% 5% 7% NS
Etiology of sepsis (not mutually exclusive)
Positive hemocultures 76/141 9/67 88/180 \0.0001a,b
Gram positive 47/141 7/67 61/180 \0.0001a,b
Gram negative 22/141 1/67 23/180 \0.0001a,b
Unknown 7/141 1/67 4/180 \0.0001a,b










Anal abscess 1 0
Peritonitis 3 2
Liver abscess 1 0
Cholangitis 0 1
Pancreatitis 9 8
Urinary tract infection 4 1
% Oliguric at AKI diagnosis 23% 23% 34% 0.022b
0.011c
Mean number of oliguric days post-AKI diagnosis 7.0 ± 10.4 days 3.1 ± 5.8 days 7.8 ± 10.5 days \0.0001a
\0.0001b
Cumulative fluid balance at AKI diagnosis (L) 6.6 ± 7.7 3.0 ± 5.3 3.7 ± 6.4 \0.0001a
0.067b
0.0002c
Mean % fluid accumulation adjusted for
body weight at AKI diagnosis
8.2 ± 9.5 4.0 ± 7.6 4.5 ± 7.6 \0.0001a
\0.0001c
Mean glucose at AKI diagnosis (mmol/L) 8.8 ± 4.3 8.4 ± 3.4 8.4 ± 2.2 NS
Mean SOFA score at AKI diagnosis 8.5 ± 3.8 5.9 ± 2.9 7.1 ± 3.8 \0.0001a
0.0003b
\0.0001c
Mechanical ventilation 61% 24% 35% \0.0001a
0.026b
\0.0001c
Pressor support 43% 28% 26% 0.002a
0.77b
0.0003c
AKI acute kidney injury, SOFA Sequential Organ Failure Assessment, NS not
significant
a Sepsis pre-AKI versus sepsis-free
b Sepsis-free versus sepsis post-AKI
c Septic pre- versus post-AKI
d Not classified include patients who did not meet the 50% increase in serum
creatinine
e Defined as ICD-9 codes 038.0–038.9
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appropriate. We examined the in-hospital time to death
using the Kaplan–Meier product limit estimate and
compared survival curves using the log-rank test.
We determined independent predictors of sepsis
developing after AKI using logistic regression. We con-
structed the model with backward selection considering
these variables: age, gender, chronic obstructive pul-
monary disease, chronic kidney disease (CKD), diabetes,
human immunodeficiency virus (HIV), hypertension,
previous chemotherapy, radiation therapy, steroid
therapy, leukemia, lymphoma, oliguria status at AKI
diagnosis (urine output B400 mL/day), oliguria C3 days,
number of oliguric days, hyperglycemia, blood urea
nitrogen (BUN) and serum osmolality, mechanical ven-
tilation at AKI diagnosis, SOFA score, surgery and non-
surgical procedures prior to AKI, antibiotic use prior to
AKI and dialysis requirement, and fluid overload status.
Effect modification was evaluated by including multipli-
cative interaction terms for selected variables. We
included in the multivariable model variables with Wald
chi-square p value C 0.10 on bivariate screening. Factors
not included in multivariable models were re-entered
individually to evaluate for residual confounding. In
logistic regression models, discrimination was assessed
by using the area under the receiver operating character-
istic (ROC) curve. Calibration was assessed by using the
Hosmer–Lemeshow goodness-of-fit test. All statistical
tests were two-sided and p \ 0.05 was considered sig-
nificant. Statistical analyses were conducted by using SAS
9.2 (SAS Institute, Cary, NC, USA).
Results
Among the 611 patients with available data on sepsis
status throughout hospitalization (99% of the 618-patient
cohort), 174 (28%) were septic prior to AKI diagnosis
(septic AKI), 194 (32%) patients remained sepsis-free,
and 243 (40%) developed sepsis 5 days (IQ range
2–9 days) after AKI diagnosis (Fig. 1). After AKI diag-
nosis was made, the incidence of sepsis post-AKI and the
time to develop sepsis post-AKI were similar in patients
who did and did not require dialysis. As opposed to
patients who remained sepsis-free, those who developed
sepsis post-AKI were more often oliguric at AKI diag-
nosis, had higher severity of illness scores, and were less
likely to have pre-existing CKD (Table 1). Compared
with patients with sepsis pre-AKI, those with sepsis post-
AKI were older, more often oliguric at AKI diagnosis,
and had lower cumulative fluid balance (Table 1). There
were no differences in the frequency and type of organ-
isms between patients who developed sepsis pre- or post-
AKI. Forty-five percent of patients with sepsis pre-AKI
and 23.5% of patients with sepsis post-AKI had one or
more infection ICD-9 code.
Among patients with AKI requiring dialysis
(n = 391), 170 (43.5%) developed sepsis after AKI.
Eighty-seven of these 170 dialyzed patients (51%) had
sepsis prior to dialysis initiation, whereas 83 (49%)
developed sepsis on average 4 days (IQ range 2–7 days)
post-dialysis initiation. In these 83 patients, the incidence
of sepsis post-continuous renal replacement therapy
(CRRT) and intermittent hemodialysis (IHD) was similar
(52 vs. 48%).
Predictors for the development of sepsis
Independent predictors of the development of incident
sepsis post-AKI included oliguria C3 days, higher per-
centages of days with fluid overload post-AKI diagnosis,
invasive non-surgical procedures post-AKI diagnosis,
high severity of illness scores, and dialysis requirement
(either intermittent or continuous renal replacement
therapy) (Table 2).
Fig. 1 Incidence and timing of
sepsis in all patients
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Timing of sepsis and outcomes
The in-hospital mortality rate was significantly higher in
patients who developed sepsis post-AKI than in patients
without sepsis through their hospital course (44 vs. 21%;
p \ 0.001) and similar to that of patients with sepsis pre-
AKI (44 vs. 48%; p = 0.41; Figs. 2, 3). In dialyzed and
non-dialyzed patients, sepsis was associated with 20%
higher absolute mortality rates, irrespective of whether
sepsis occurred before or after AKI (Fig. 4). In patients
with sepsis post-AKI, the mortality rate was similar
regardless of the timing of sepsis post-AKI (38% for
sepsis within 3 days, 51% after 4 to 10 days, and 42%
after 10 days following AKI diagnosis; p = 0.18).
Additionally, in-hospital mortality rates were similar
regarding the timing of sepsis in relation to dialysis ini-
tiation (54 vs. 46% before or after dialysis initiation;
p = 0.28). Compared with patients who remained sepsis-
free, those with sepsis post-AKI were also more likely to
be dialyzed (70 vs. 50%; p \ 0.001) and had longer
median lengths of stay (37 vs. 27 days; p \ 0.001). When
evaluating mortality, lengths of stay and rates of recovery
of kidney function, results were similarly poor whether
sepsis developed before or after AKI. Patients with sepsis
pre-AKI were similar to patients with sepsis post-AKI in
terms of dialysis requirements and length of stay. How-
ever, dialysis treatments were initiated earlier after AKI
diagnosis in patients with sepsis pre-AKI than among
patients who developed sepsis post-AKI (4.1 ± 5.6 vs.
6.0 ± 6.7 days after AKI diagnosis; p \ 0.008).
Discussion
Acute kidney injury (AKI) is common among critically ill
patients, and is associated with high mortality rates
([50%) and substantial and wide-ranging morbidity
[2, 19, 20]. Few patients with established AKI expire
because of complications that are directly remediable
with medications or dialysis, such as hyperkalemia or
pericarditis, and the mechanism(s) responsible for mor-
tality and morbidity associated with AKI remain elusive.
Many investigators have attempted to identify clinical
factors that can serve as mortality predictors to aid in
prognostic stratification after AKI, especially when the
disease process is severe enough to require dialysis [21].
Previous studies have reported that sepsis causes or con-
tributes to AKI in 32–48% of patients [6, 8, 10]. Whereas
several studies have focused on sepsis-induced AKI, there
are sparse data on the incidence, time course, risk factors,
and prognosis of sepsis developing after AKI [13].
In the present study, 28% of patients had sepsis before
AKI. Interestingly, 56% of patients who were not septic at
the time of AKI diagnosis subsequently developed sepsis
later in the hospital course. This percentage is similar to
that previously reported in a smaller, single-center study
of contrast-induced AKI (45%; 21/47 patients) [13]. In
our study, patients with sepsis had an absolute mortality
rate 20% higher than patients who remained sepsis-free,
regardless of when sepsis developed. It is noteworthy that
Table 2 Significant predictors of incident sepsis after the diagnosis of acute kidney injury
Logistic regression
Incidence of sepsis post-AKI diagnosisa
Parameter Coefficient OR 95% CI
Intercept -1.1319
Chronic kidney disease -0.9142 0.40 0.26–0.63
Steroid therapy 0.6554 1.93 0.99–3.74
At least 3 days of oliguriab 1.2236 3.40 1.49–7.76
SOFA score at AKI diagnosis (per 1 point of score) 0.1086 1.12 1.04–1.20
[25% of post-AKI days with cumulative fluid balance [10% of body weight 0.5078 1.66 1.05–2.64
Provision of dialysis 0.4552 1.58 1.01–2.45
Invasive non-surgical procedure post-AKI 0.5571 1.75 1.15–2.66
AKI acute kidney injury, SOFA Sequential Organ Failure
Assessment
a Area under ROC curve = 0.74, Hosmer–Lemeshow x2 = 0.57
b Days of oliguria prior to sepsis in septic patients, prior to end of
nephrology consult in non-septic patients
Fig. 2 Kaplan–Meier mortality estimates, by sepsis status over
hospitalization (p = 0.005 between all groups)
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patients with AKI who remained sepsis-free had in-hos-
pital mortality of ‘‘only’’ 21%. This finding hints that
studies focusing on surveillance for, and prevention of,
infection may have the potential to relieve a fraction of
the immense burden of mortality and morbidity currently
experienced by critically ill patients with AKI.
Several factors have emerged as predictors of sepsis
developing after AKI diagnosis. Previous studies have
found that patients with sepsis-induced AKI were more
likely to be oliguric than patients with AKI due to other
causes [6]. Our study expands these results and showed
that oliguria C3 days was also associated with sepsis after
AKI. Several previous studies have examined the asso-
ciation of fluid accumulation with sepsis [22, 23]. We
recently reported that the amount and duration of fluid
overload was strongly associated with mortality in this
cohort [17]. When contemplating potential mechanisms
explaining these associations, we note that it has been
increasingly recognized that fluid accumulation leads to
soft tissue and gut edema, which can impair barriers to
infection; in particular, bowel edema may facilitate
translocation of gut flora, potentially contributing to the
development of sepsis and multiorgan failure [24–26].
Acute kidney injury has also been recognized as an
immunocompromised state, associated with impaired
monocyte cytokine production and elevated plasma
cytokine levels [27]. Previous studies showed that patients
with sepsis-induced AKI had higher severity of illness
scores compared with patients with other causes of AKI
[6]. Prior use of steroids and a higher severity of illness
score emerged as predictors of sepsis in our study, pos-
sibly representing additional effects on the immune
response. Interestingly, invasive non-surgical procedures
performed after the diagnosis of AKI was established
were associated with the development of sepsis, inde-
pendent of the provision of dialysis. Although dialysis
was an important predictor of sepsis after AKI diagnosis,
the time to develop sepsis was similar in patients who did
and did not require dialysis and in whom a dialysis
catheter was or was not installed, suggesting that dialysis
catheter is not the only, or necessarily the most important,
source of sepsis post-AKI. Dialysis modality (continuous
vs. intermittent) was unrelated to the incidence or time to
develop sepsis. Contamination of replacement fluids may
rarely occur during CRRT [28], and in IHD, backfiltration
of non-sterile dialysate (particularly when dialysis is
performed without concomitant ultrafiltration) may result
Fig. 3 Outcomes according to
sepsis status
Fig. 4 In-hospital mortality rate stratified for sepsis and dialysis
status
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in exposure to lipopolysaccharide and/or other contami-
nants that could contribute to sepsis or SIRS. Other as yet
undetermined factors associated with dialysis might
explain the association of dialysis and sepsis after AKI.
Our study has several strengths. We included patients
from five tertiary care academic medical centers across the
USA with different demographics and clinical conditions,
increasing the generalizability of our results. Patients had
detailed data on their sepsis status serially during hospi-
talization. There are also important limitations. First, only
patients with a nephrology consultation were included.
Patients, or their proxies, were required to sign informed
consent [29]. Thus, patients included in PICARD may be
slightly healthier than ‘‘all comers’’ with AKI in intensive
care units. Second, since sepsis is a clinical diagnosis, its
diagnosis could have been delayed in some patients. It is
also possible that patients with ‘‘smoldering’’ infection
prior to diagnosis of AKI could have been misclassified as
having sepsis post-AKI. Third, we did not have data on the
exact etiology of sepsis with ICD-9 codes and positive
blood culture results for all patients, although in practice,
approximately 50% of patients with severe sepsis dem-
onstrate bacteremia at the time of diagnosis [30]. As
mentioned, although we found a high incidence of sepsis
post-AKI, we have not assessed the underlying mecha-
nisms leading to sepsis in these patients. Previous data
from PICARD showed abnormalities in several pathways,
including cytokines, insulin resistance, and oxidative
stress [27, 31, 32]. Additionally, we have identified key
factors with biological plausibility in imparting additional
risk (e.g., fluid accumulation, invasive procedures, and the
provision of dialysis). A better knowledge of the focus of
infections and specific preventive measures against noso-
comial infections could have helped to better understand
the pathophysiology of sepsis post-AKI. We did not have
data on specific prophylactic measures applied in all or any
of the hospitals participating in PICARD. However,
standard prophylactic measures for infection control were
followed in all the centers.
Conclusions
In this study, more than half of patients with AKI free of
sepsis at the time of AKI diagnosis developed sepsis
during hospitalization, and half of them within 5 days
after AKI diagnosis. The development of sepsis following
AKI has a similar prognosis as sepsis occurring before
AKI diagnosis and can contribute to the overall poor
prognosis in this patient population. Prospective studies
are required to assess the derangements in host response
that occur following AKI. Once the mechanisms under-
lying sepsis pre- and post-AKI are better understood, a
well-informed clinical trial could be designed in an effort
to reduce the frequency of, and adverse consequences
caused by, sepsis following AKI. New strategies might
help to reduce the exceptionally high rate of mortality and
morbidity associated with AKI in the critically ill.
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